Novartis AG Recalls Introvale Birth Control Pills Over Packaging Flaw
Published: Jun 08, 2012
The U.S. Food and Drug Administration said Wednesday that a Novartis AG (NVS, NOVN.VX) unit is recalling a three-month birth-control regimen sold in the U.S. because of a packing error. The recall involves a birth-control pill called Introvale that is marketed by Sandoz. The product contains 84 active pills that are peach colored and seven inactive pills in week 13 that are white. FDA said the recall, which affects 10 lots distributed between January and May 2012, was prompted by a consumer report of the inactive pills being located in the row labeled week nine.